Cargando…
Successful management of refractory pleural effusion due to systemic immunoglobulin light chain amyloidosis by vincristine adriamycin dexamethasone chemotherapy: a case report
INTRODUCTION: Refractory pleural effusion in systemic immunoglobulin light chain amyloidosis without cardiac decompensation is rarely reported and has a poor prognosis in general (a median survival of 1.6 months). Moreover, the optimum treatment for this condition is still undecided. This is the fir...
Autores principales: | Araoka, Toshikazu, Takeoka, Hiroya, Nishioka, Keisuke, Ikeda, Masaki, Kondo, Makiko, Hoshina, Azusa, Kishi, Seiji, Araki, Makoto, Mimura, Rokuro, Murakami, Taichi, Mima, Akira, Nagai, Kojiro, Abe, Hideharu, Doi, Toshio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967566/ https://www.ncbi.nlm.nih.gov/pubmed/20955545 http://dx.doi.org/10.1186/1752-1947-4-322 |
Ejemplares similares
-
Vincristine, adriamycin and high dose steroids in myeloma complicated by renal failure.
por: Aitchison, R. G., et al.
Publicado: (1990) -
Vincristine alleviates adriamycin-induced nephropathy through stabilizing actin cytoskeleton
por: Yin, Lei, et al.
Publicado: (2017) -
Dual Involvement of Growth Arrest-Specific Gene 6 in the Early Phase of Human IgA Nephropathy
por: Nagai, Kojiro, et al.
Publicado: (2013) -
IgA Nephropathy after Nivolumab Therapy for Postoperative Recurrence of Lung Squamous Cell Carcinoma
por: Kishi, Seiji, et al.
Publicado: (2017) -
Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients.
por: Forgeson, G. V., et al.
Publicado: (1988)